DE60015153D1 - Isomere kondensierte pyrrolocarbazole und isoindolone - Google Patents

Isomere kondensierte pyrrolocarbazole und isoindolone

Info

Publication number: DE60015153D1
Authority: DE; Germany
Prior art keywords: isomere; isoindolone; condensed pyrrolocarbazole; directed; same
Prior art date: 1999-08-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60015153T

Other languages

English (en)

Other versions

DE60015153T2 (de

Inventor

L Hudkins

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Cephalon LLC

Original Assignee

Cephalon LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-08-20

Filing date

2000-08-18

Publication date

2004-11-25

2000-08-18 Application filed by Cephalon LLC filed Critical Cephalon LLC

2004-11-25 Publication of DE60015153D1 publication Critical patent/DE60015153D1/de

2006-02-09 Application granted granted Critical

2006-02-09 Publication of DE60015153T2 publication Critical patent/DE60015153T2/de

2020-08-19 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Dermatology (AREA)
Psychology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Rheumatology (AREA)
Ophthalmology & Optometry (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Pyrrole Compounds (AREA)
Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Indole Compounds (AREA)

DE60015153T 1999-08-20 2000-08-18 Isomere kondensierte pyrrolocarbazole und isoindolone Expired - Lifetime DE60015153T2 (de)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US15036799P	1999-08-20	1999-08-20
US150367P		1999-08-20
US640825		2000-08-17
US09/640,825 US6399780B1 (en)	1999-08-20	2000-08-17	Isomeric fused pyrrolocarbazoles and isoindolones
PCT/US2000/022724 WO2001014380A1 (en)	1999-08-20	2000-08-18	Isomeric fused pyrrolocarbazoles and isoindolones

Publications (2)

Publication Number	Publication Date
DE60015153D1 true DE60015153D1 (de)	2004-11-25
DE60015153T2 DE60015153T2 (de)	2006-02-09

Family

ID=26847579

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60015153T Expired - Lifetime DE60015153T2 (de)	1999-08-20	2000-08-18	Isomere kondensierte pyrrolocarbazole und isoindolone

Country Status (26)

Country	Link
US (4)	US6399780B1 (de)
EP (1)	EP1206473B1 (de)
JP (1)	JP4776842B2 (de)
KR (1)	KR100756686B1 (de)
CN (1)	CN1370173A (de)
AT (1)	ATE280172T1 (de)
AU (1)	AU776475C (de)
BG (1)	BG65545B1 (de)
BR (1)	BR0013811A (de)
CA (1)	CA2381885C (de)
CZ (1)	CZ2002616A3 (de)
DE (1)	DE60015153T2 (de)
EA (1)	EA005920B1 (de)
ES (1)	ES2230140T3 (de)
HK (1)	HK1046904B (de)
HU (1)	HUP0202758A3 (de)
IL (2)	IL148180A0 (de)
IS (1)	IS2186B (de)
MX (1)	MXPA02001789A (de)
NO (1)	NO323375B1 (de)
NZ (1)	NZ517174A (de)
PL (1)	PL354180A1 (de)
PT (1)	PT1206473E (de)
SK (1)	SK286805B6 (de)
TR (1)	TR200200474T2 (de)
WO (1)	WO2001014380A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6399780B1 (en) *	1999-08-20	2002-06-04	Cephalon, Inc.	Isomeric fused pyrrolocarbazoles and isoindolones
US7122679B2 (en) *	2000-05-09	2006-10-17	Cephalon, Inc.	Multicyclic compounds and the use thereof
AR035971A1 (es) *	2001-05-16	2004-07-28	Cephalon Inc	Metodos para el tratamiento y la prevencion del dolor
WO2003027093A1 (en) *	2001-09-21	2003-04-03	Smithkline Beecham Corporation	Chemical compounds
SE0104140D0 (sv) *	2001-12-07	2001-12-07	Astrazeneca Ab	Novel Compounds
AU2003304238A1 (en) *	2002-10-08	2005-01-13	Rinat Neuroscience Corp.	Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist antibody and compositions containing the same
UA80447C2 (en) *	2002-10-08	2007-09-25		Methods for treating pain by administering nerve growth factor antagonist and opioid analgesic
MXPA05003502A (es)	2002-10-08	2005-09-30	Rinat Neuroscience Corp	Metodo para tratar dolor post-quirurgico al administrar un antagonista del factor de crecimiento de nervios y composiciones que contienen el mismo.
US9498530B2 (en)	2002-12-24	2016-11-22	Rinat Neuroscience Corp.	Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
PT2263692T (pt) *	2002-12-24	2018-11-28	Rinat Neuroscience Corp	Anticorpos anti-ngf e métodos de utilização dos mesmos
US7569364B2 (en) *	2002-12-24	2009-08-04	Pfizer Inc.	Anti-NGF antibodies and methods using same
US7655231B2 (en) *	2003-02-19	2010-02-02	Pfizer Inc.	Methods for treating pain by administering a nerve growth factor antagonist and an NSAID
US7169802B2 (en)	2003-12-23	2007-01-30	Cephalon, Inc.	Fused pyrrolocarbazoles
KR101637908B1 (ko) *	2004-04-07	2016-07-11	리나트 뉴로사이언스 코프.	신경성장인자 길항제의 투여에 의한 골암 통증의 치료방법
US20060058250A1 (en) *	2004-09-10	2006-03-16	Cephalon, Inc.	Methods of treating proliferative skin diseases using carbazole derivatives
EP1804818A4 (de) *	2004-09-17	2009-07-22	Ford Henry Health System	Verfahren und zusammensetzungen zur verwendung von angiogenese-inhibitoren zur vorbeugung und/oder steuerung von epilepsien
ATE530545T1 (de)	2005-02-04	2011-11-15	Astrazeneca Ab	Als kinaseinhibitoren geeignete pyrazolylaminopyridinderivate
RU2405780C2 (ru) *	2005-02-16	2010-12-10	Астразенека Аб	Химические соединения
BRPI0608160A2 (pt) *	2005-02-16	2010-11-09	Astrazeneca Ab	anticorpo isolado, célula hospedeira, método de inibir o crescimento de células psma+, e, uso de um anticorpo anti-psma defucosilado
WO2006123113A2 (en) *	2005-05-16	2006-11-23	Astrazeneca Ab	Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
TW200800963A (en) *	2005-10-28	2008-01-01	Astrazeneca Ab	Chemical compounds
CA2649043C (en)	2006-04-19	2013-09-17	Astellas Pharma Inc.	Azolecarboxamide derivative
US20080021013A1 (en) *	2006-07-21	2008-01-24	Cephalon, Inc.	JAK inhibitors for treatment of myeloproliferative disorders
JP2010500961A (ja) *	2006-08-02	2010-01-14	武田薬品工業株式会社	α−カルボリン誘導体およびその製造方法
EP2081892A4 (de) *	2006-11-17	2014-03-05	Donald F Weaver	Verbindungen und verfahren zur behandlung von proteinfaltungserkrankungen
WO2010131855A2 (ko)	2009-05-13	2010-11-18	덕산하이메탈(주)	오원자 헤테로고리를 포함하는 화합물 및 이를 이용한 유기전기소자, 그 단말
EP2155742A1 (de) *	2007-04-18	2010-02-24	AstraZeneca AB	5-aminopyrazol-3-yl-3h-imidazo[4,5-b]pyridinderivate und ihre verwendung zur behandlung von krebs
UA99459C2 (en) *	2007-05-04	2012-08-27	Астразенека Аб	9-(pyrazol-3-yl)- 9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidazo[4,5-b]pyridin-5-amine derivatives and their use for the treatment of cancer
JP2010526048A (ja) *	2007-05-04	2010-07-29	アストラゼネカアクチボラグ	アミノ−チアゾリル−ピリミジン誘導体、および癌の治療のための該誘導体の使用
SI2206707T1 (sl)	2007-10-24	2014-11-28	Astellas Pharma Inc.	Azolkarboksamidna spojina ali njena sol
JP5240205B2 (ja)	2008-01-11	2013-07-17	アステラス製薬株式会社	精巣の疼痛又は不快感行動及び頻尿併発モデル動物
TW201006830A (en) *	2008-06-11	2010-02-16	Astrazeneca Ab	Chemical compounds
TW201018693A (en) *	2008-09-30	2010-05-16	Astrazeneca Ab	Chemical compounds 496-1p
MX2011005055A (es)	2008-11-19	2011-05-31	Cephalon Inc	Nuevas formas de un compuesto de indazolo [5,4-a]pirrolo[3,4-c]car bazol.
US9233923B2 (en)	2009-03-30	2016-01-12	Duk San Neolux Co., Ltd.	Organic compounds for organic electronic devices and terminals
HUE058226T2 (hu)	2010-08-19	2022-07-28	Zoetis Belgium S A	NGF elleni antitestek és alkalmazásuk
KR101497122B1 (ko) *	2011-08-09	2015-03-06	덕산네오룩스 주식회사	2개 이상의 오원자 헤테로고리를 포함하는 화합물 및 이를 이용한 유기전기소자, 그 단말
TWI585088B (zh)	2012-06-04	2017-06-01	第一三共股份有限公司	作爲激酶抑制劑之咪唑并［１，２－ｂ］嗒衍生物
EP2859018B1 (de)	2012-06-06	2021-09-22	Zoetis Services LLC	Anti-ngf-antikörper für hunde und verfahren dafür
KR101478884B1 (ko)	2012-12-24	2015-01-05	충남대학교산학협력단	비스인돌일말레이미드계 화합물 및 이의 제조방법
WO2019101843A1 (en)	2017-11-23	2019-05-31	Biomed X Gmbh	Pyrimidine derivatives as tropomyosin receptor kinase a (trka) inhibitors
JP2021517461A (ja)	2018-03-12	2021-07-26	ゾエティス・サービシーズ・エルエルシー	抗ｎｇｆ抗体およびその方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4816450A (en)	1986-09-15	1989-03-28	Duke University	Inhibition of protein kinase C by long-chain bases
US4735939A (en)	1987-02-27	1988-04-05	The Dow Chemical Company	Insecticidal activity of staurosporine
US4923986A (en)	1987-03-09	1990-05-08	Kyowa Hakko Kogyo Co., Ltd.	Derivatives of physiologically active substance K-252
JPH07113027B2 (ja)	1987-12-24	1995-12-06	協和醗酵工業株式会社	Ｋ−２５２誘導体
FR2631199B1 (fr)	1988-05-09	1991-03-15	Centre Nat Rech Scient	Reacteur a plasma
US5621101A (en)	1992-07-24	1997-04-15	Cephalon, Inc.	Protein kinase inhibitors for treatment of neurological disorders
DE69409641T2 (de)	1993-05-28	1998-11-26	Cephalon, Inc., West Chester, Pa.	Anwendung von indolocarbazol-derivaten zur behandlung von prostataerkrankungen
US5624949A (en)	1993-12-07	1997-04-29	Eli Lilly And Company	Protein kinase C inhibitors
ES2236702T3 (es)	1993-12-23	2005-07-16	Eli Lilly And Company	Inhibidores de la proteina quinasa c.
US5545636A (en)	1993-12-23	1996-08-13	Eli Lilly And Company	Protein kinase C inhibitors
GB9416467D0 (en) *	1994-08-13	1994-10-05	Wellcome Found	Compounds for use in medicine
US5591855A (en) *	1994-10-14	1997-01-07	Cephalon, Inc.	Fused pyrrolocarbazoles
US5705511A (en) *	1994-10-14	1998-01-06	Cephalon, Inc.	Fused pyrrolocarbazoles
US5594009A (en) *	1994-10-14	1997-01-14	Cephalon, Inc.	Fused pyrrolocarbazoles
US5475110A (en) *	1994-10-14	1995-12-12	Cephalon, Inc.	Fused Pyrrolocarbazoles
DK0776895T3 (da)	1995-11-20	1999-06-23	Lilly Co Eli	Proteinkinase C inhibitor
US5808060A (en) *	1995-12-11	1998-09-15	Cephalon, Inc.	Fused isoindolones
US5616724A (en) *	1996-02-21	1997-04-01	Cephalon, Inc.	Fused pyrrolo[2,3-c]carbazole-6-ones
HUP9903931A3 (en)	1996-08-22	2000-09-28	Bristol Myers Squibb Co Wallin	Cytotoxic amino sugar and related sugar derivatives of indolopyrrolocarbazoles
US6399780B1 (en) *	1999-08-20	2002-06-04	Cephalon, Inc.	Isomeric fused pyrrolocarbazoles and isoindolones

2000
- 2000-08-17 US US09/640,825 patent/US6399780B1/en not_active Expired - Lifetime
- 2000-08-18 PL PL00354180A patent/PL354180A1/xx unknown
- 2000-08-18 DE DE60015153T patent/DE60015153T2/de not_active Expired - Lifetime
- 2000-08-18 EA EA200200271A patent/EA005920B1/ru not_active IP Right Cessation
- 2000-08-18 WO PCT/US2000/022724 patent/WO2001014380A1/en not_active Ceased
- 2000-08-18 AU AU66471/00A patent/AU776475C/en not_active Ceased
- 2000-08-18 AT AT00954136T patent/ATE280172T1/de active
- 2000-08-18 EP EP00954136A patent/EP1206473B1/de not_active Expired - Lifetime
- 2000-08-18 CA CA002381885A patent/CA2381885C/en not_active Expired - Fee Related
- 2000-08-18 CN CN00811850A patent/CN1370173A/zh active Pending
- 2000-08-18 NZ NZ517174A patent/NZ517174A/en unknown
- 2000-08-18 TR TR2002/00474T patent/TR200200474T2/xx unknown
- 2000-08-18 IL IL14818000A patent/IL148180A0/xx active IP Right Grant
- 2000-08-18 MX MXPA02001789A patent/MXPA02001789A/es active IP Right Grant
- 2000-08-18 BR BR0013811-8A patent/BR0013811A/pt not_active Application Discontinuation
- 2000-08-18 SK SK246-2002A patent/SK286805B6/sk not_active IP Right Cessation
- 2000-08-18 ES ES00954136T patent/ES2230140T3/es not_active Expired - Lifetime
- 2000-08-18 PT PT00954136T patent/PT1206473E/pt unknown
- 2000-08-18 CZ CZ2002616A patent/CZ2002616A3/cs unknown
- 2000-08-18 HK HK02108409.6A patent/HK1046904B/en not_active IP Right Cessation
- 2000-08-18 JP JP2001518711A patent/JP4776842B2/ja not_active Expired - Fee Related
- 2000-08-18 KR KR1020027002117A patent/KR100756686B1/ko not_active Expired - Fee Related
- 2000-08-18 HU HU0202758A patent/HUP0202758A3/hu unknown
2002
- 2002-02-01 US US10/062,159 patent/US6635669B2/en not_active Expired - Lifetime
- 2002-02-12 IS IS6266A patent/IS2186B/is unknown
- 2002-02-14 IL IL148180A patent/IL148180A/en not_active IP Right Cessation
- 2002-02-19 NO NO20020809A patent/NO323375B1/no not_active IP Right Cessation
- 2002-02-21 BG BG106423A patent/BG65545B1/bg unknown
2003
- 2003-04-24 US US10/422,164 patent/US6872746B2/en not_active Expired - Fee Related
2005
- 2005-01-05 US US11/029,330 patent/US7291732B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
JP2003507480A (ja)	2003-02-25
HUP0202758A2 (hu)	2002-12-28
NO20020809L (no)	2002-02-20
PL354180A1 (en)	2003-12-29
HK1046904A1 (en)	2003-01-30
BR0013811A (pt)	2002-07-23
WO2001014380A1 (en)	2001-03-01
CZ2002616A3 (cs)	2003-04-16
NO20020809D0 (no)	2002-02-19
US20050107458A1 (en)	2005-05-19
US20020147341A1 (en)	2002-10-10
PT1206473E (pt)	2005-01-31
BG65545B1 (bg)	2008-11-28
HUP0202758A3 (en)	2004-12-28
KR20020038730A (ko)	2002-05-23
CN1370173A (zh)	2002-09-18
CA2381885C (en)	2009-10-27
IL148180A (en)	2008-04-13
EP1206473B1 (de)	2004-10-20
DE60015153T2 (de)	2006-02-09
AU776475B2 (en)	2004-09-09
MXPA02001789A (es)	2003-07-14
SK2462002A3 (en)	2002-12-03
SK286805B6 (sk)	2009-05-07
EA200200271A1 (ru)	2002-08-29
NZ517174A (en)	2003-09-26
US20030216419A1 (en)	2003-11-20
KR100756686B1 (ko)	2007-09-07
IS2186B (is)	2006-12-15
JP4776842B2 (ja)	2011-09-21
US7291732B2 (en)	2007-11-06
NO323375B1 (no)	2007-04-16
CA2381885A1 (en)	2001-03-01
EP1206473A1 (de)	2002-05-22
ES2230140T3 (es)	2005-05-01
AU6647100A (en)	2001-03-19
TR200200474T2 (tr)	2002-06-21
IL148180A0 (en)	2002-09-12
ATE280172T1 (de)	2004-11-15
US6872746B2 (en)	2005-03-29
US6399780B1 (en)	2002-06-04
US6635669B2 (en)	2003-10-21
IS6266A (is)	2002-02-12
BG106423A (en)	2002-09-30
EA005920B1 (ru)	2005-08-25
AU776475C (en)	2005-04-07
HK1046904B (en)	2005-05-06

Publication	Publication Date	Title
DE60015153D1 (de)	2004-11-25	Isomere kondensierte pyrrolocarbazole und isoindolone
MXPA02004415A (es)	2004-09-10	Pirazolonas sustituidas con heterociclicas.
EA200100589A1 (ru)	2002-02-28	Азабициклоалканы как модуляторы ccr5
NO20030845D0 (no)	2003-02-24	Utvalgte fusjonerte pyrrolokarbazoler
EA200100588A1 (ru)	2002-02-28	Пиперидины как модуляторы ccr5
AU4802797A (en)	1998-04-24	4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv rever se transcriptase inhibitors and intermediates and processes for making the same
EA200100887A1 (ru)	2002-02-28	Циклические замещенные конденсированные пирролкарбазолы и изоиндолоны
DE60107687D1 (de)	2005-01-13	Cyclpentanoindole, mischungen derartige verbindungen enthaltend und behandlungsmethoden
TR199901710T2 (xx)	1999-09-21	IL-8 resept�r antagonistleri.
DE69737683D1 (de)	2007-06-14	Antikörper gegen die ed-b domäne von fibronektin, ihre herstellung und verwendungen
WO2001029037A3 (en)	2002-01-24	Condensed naphthyridines as hiv reverse transcriptase inhibitors
DE69919700D1 (de)	2004-09-30	Überbrückte indenopyrrolocarbazole
SE9904129D0 (sv)	1999-11-15	Novel compounds
YU62504A (sh)	2006-08-17	Triciklična 2-pirimidonska jedinjenja korisna kao inhibitori hiv reverzne transkriptoze
TR199901761T2 (xx)	1999-10-21	IL-8 resept�r antagonistleri.
EE200200326A (et)	2003-10-15	Asendatud homopiperidüülbensimidasooli analoog, meetod selle valmistamiseks ning seda sisaldav farmatseutiline kompositsioon
LT2003003A (en)	2003-11-25	Tricyclic 2-pyridone compounds useful as hiv reverse transcriptase inhibitors
EA199700223A1 (ru)	1998-04-30	Бициклические антагонисты тахикининов, их получение и применение в фармацевтической композиции
EA200200981A1 (ru)	2003-02-27	Антагонисты рецептора il-8
ATE244714T1 (de)	2003-07-15	1-(3-aminoindazol-5-yl)-3-phenylmethyl cyclische harnstoffe und ihre verwendung als hiv protease inhibitoren
LV12374A (lv)	1999-11-20	(4R,5S,6S,7R)-Heksahidro-1-(5-(3-aminoindazol)metil)-3-butil-5,6-dioksi-4,7-bis(fenilmetil)-2H-1,3-diazepin-2-ons si savienojuma iegusana un ka HIV proteazes inhibitora pielietojums
WO2000073284A3 (en)	2001-04-05	1,4-benzodiazepin-2-ones useful as hiv reverse transcriptase inhibitors
ATE362934T1 (de)	2007-06-15	Verbrückte bicyclische (1,4) benzodiazepine als vasopressinrezeptorantagonisten

Legal Events

Date	Code	Title	Description
2005-12-08	8364	No opposition during term of opposition